• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Coronary-artery bypass surgery in stable angina pectoris: Survival at two years. European Coronary Surgery Study Group.

出版信息

Lancet. 1979 Apr 28;1(8122):889-93.

PMID:86665
Abstract

768 men aged under 65 with angina pectoris, at least 50% obstruction in two or more major vessels, and a left-ventricular ejection fraction greater than or equal to 0.5 took part in a prospective randomised trial of the effect of coronary-artery bypass on prognosis. 373 patients were alloted to medical and 395 to surgical treatment. There was no significant difference between the two groups in the distribution of variables recorded at the time of randomisation. 1. "surgical" patient was lost to follow-up. 26 "surgical" patients did not undergo surgery and 50 "medical" patients were operated on. All these 76 patients were retained in their original treatment groups for the analysis. At 2 years there was no significant difference in mortality between the two groups. A significant difference was, however, found in the subset of patients with three-vessel disease, survival being significantly better for surgical patients. Operative (in-hospital) mortality was 3.6% in all operated patients and 1.5% in the last third. On average, 1.9 grafts per patient were inserted in the two-vessel-disease subgroup and 2.4 grafts per patient in the three-vessel-disease subgroup. Graft-patency rate was 90% within 9 months and 77% between 9 and 18 months after surgery. Symptomatic improvement was significantly better and deterioration less in the surgical group.

摘要

相似文献

1
Coronary-artery bypass surgery in stable angina pectoris: Survival at two years. European Coronary Surgery Study Group.
Lancet. 1979 Apr 28;1(8122):889-93.
2
Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. European Coronary Surgery Study Group.稳定型心绞痛冠状动脉搭桥手术前瞻性随机研究的长期结果。欧洲冠状动脉外科研究组。
Lancet. 1982 Nov 27;2(8309):1173-80.
3
Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery.
Circulation. 1985 Dec;72(6 Pt 2):V90-101.
4
Prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Second interim report by the European Coronary Surgery Study Group.
Lancet. 1980 Sep 6;2(8193):491-5.
5
Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study.
N Engl J Med. 1987 Apr 16;316(16):977-84. doi: 10.1056/NEJM198704163161603.
6
Characteristics of patients younger than 40 years of age operated for coronary artery disease.
Herz. 1996 Jun;21(3):183-91.
7
Indications for coronary artery bypass surgery in patients with chronic angina pectoris: implications of the multicenter randomized trials.
Circulation. 1985 Dec;72(6 Pt 2):V23-30.
8
Surgical treatment of unstable angina by saphenous vein and internal mammary artery bypass grafting.采用大隐静脉和乳内动脉搭桥术治疗不稳定型心绞痛
J Thorac Cardiovasc Surg. 1976 Mar;71(3):348-54.
9
Bypass grafts to the left anterior descending coronary artery: saphenous vein versus internal mammary artery.冠状动脉左前降支搭桥术:大隐静脉与乳内动脉的比较
J Thorac Cardiovasc Surg. 1980 Sep;80(3):327-33.
10
Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study.
N Engl J Med. 1977 Sep 22;297(12):621-7. doi: 10.1056/NEJM197709222971201.

引用本文的文献

1
ISCHEMIA Trial: Key Questions and Answers.缺血试验:关键问题与解答。
Eur Cardiol. 2021 Sep 14;16:e34. doi: 10.15420/ecr.2021.16. eCollection 2021 Feb.
2
Lifestyle Medicine Philippines: A Journey of Hope.菲律宾生活方式医学:希望之旅。
Am J Lifestyle Med. 2020 Sep 4;14(6):615-617. doi: 10.1177/1559827620951752. eCollection 2020 Nov-Dec.
3
Predictive Model for High-Risk Coronary Artery Disease.高危冠状动脉疾病预测模型。
Circ Cardiovasc Imaging. 2019 Feb;12(2):e007940. doi: 10.1161/CIRCIMAGING.118.007940.
4
Complete versus incomplete coronary revascularization of patients with multivessel coronary artery disease.多支冠状动脉疾病患者的完全性与不完全性冠状动脉血运重建
Curr Treat Options Cardiovasc Med. 2015 Mar;17(3):366. doi: 10.1007/s11936-015-0366-1.
5
Safe introduction and quality control of new methods in coronary surgery.冠状动脉手术新方法的安全引入与质量控制。
Acta Inform Med. 2011 Dec;19(4):203-15. doi: 10.5455/aim.2011.19.203-215.
6
Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.初始血运重建策略与最佳药物治疗改善缺血性心脏病结局的比较:文献复习。
Curr Cardiol Rep. 2012 Aug;14(4):397-407. doi: 10.1007/s11886-012-0278-6.
7
Modified intention to treat reporting in randomised controlled trials: systematic review.修改后的意向治疗报告在随机对照试验中的系统评价。
BMJ. 2010 Jun 14;340:c2697. doi: 10.1136/bmj.c2697.
8
Trials and tribulations associated with angina and traditional therapeutic approaches.与心绞痛及传统治疗方法相关的试验与磨难。
Clin Cardiol. 2007 Feb;30(2 Suppl 1):I16-24. doi: 10.1002/clc.20049.
9
Revascularize only for ischemia, especially if left ventricular function is poor.
J Nucl Cardiol. 2006 Nov;13(6):742-6. doi: 10.1016/j.nuclcard.2006.09.006.
10
Will drug-eluting stents replace coronary artery bypass surgery?药物洗脱支架会取代冠状动脉搭桥手术吗?
Tex Heart Inst J. 2005;32(3):323-30.